Substitutions Approved For Shortage Of Catapres (clonidine) 150 Mcg Tablets
Summary There is a shortage of Catapres (clonidine) 150 mcg tablets in Australia from December 22, 2025 to April 28, 2026. During this period, pharmacists are allowed to substitute this medication with clonidine 100 mcg tablets without requiring a new prescription from your doctor. This temporary measure applies across Australia to ensure patients can continue to access clonidine treatment while supplies of the 150 mcg dose are limited.
- Reason
- The initial Serious Scarcity Substitution Instrument (SSSI) has been extended - refer to new medicine shortage alert: "Extension of substitution approval for shortage of Catapres (clonidine) 150 mcg tablets"
- Classification
- Class III
- Category
- drug recall
- Country
- Australia
- Agency
- Therapeutic Goods Administration
- Recall date
- 2025-12-22
- Status
- Ongoing
- Distribution
- Australia-wide
Official recall notice from Therapeutic Goods Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/1b6d11b8-54ad-4646-bca6-d3480fb69626